Novadip Biosciences’s bone grafting material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa proof-of-concept study. The Belgian company’s NVDX3-CLN01 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel synthetic bone graft showed noninferiority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback